CONTROL BIONICS LIMITED — Investor Presentation 2021

Nov 23, 2021

control bionics MoRGANs TECHNOLOGY CONFERENCE November 24 2021

==> picture [178 x 83] intentionally omitted <==

Morgans Technology Conference | November 24, 2021

Control Bionics Limited ABN 45 115 465 462

Disclaimer

This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter covered in it. The information in this presentation, whether written or verbal, has been prepared without taking into account the commercial, financial or other needs of any individual or organisation. Certain information may relate to protected intellectual property rights owned by Control Bionics Limited (Control Bionics) and its subsidiaries (together the Group). While due care has been taken in compiling the information based on the information available to Control Bionics at the date of the presentation material, neither Control Bionics nor its officers or advisors or any other person warrants the accuracy, reliability, completeness or timeliness of the information or guarantees the commercial or investment performance of the Group.

The information does not constitute advice of any kind and should not be relied upon as such. Investors must make their own independent assessment of the Group and undertake such additional enquiries as they deem necessary or appropriate for their own investment purposes. Any and all use of the information is at your own risk. No representation, warranty or assurance (express or implied) is given or made in relation to any forward looking statement by any person (including Control Bionics). In particular, no representation, warranty or assurance (express or implied) is given in relation to any underlying assumptions or that any forward looking statement will be achieved. Actual future events may vary materially from the forward looking statements and the assumptions on which the forward looking statements are based. Subject to any continuing obligations under applicable law or any relevant listing rules of the Australian Securities Exchange, Control Bionics disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements in these materials to reflect any change in expectations in relation to any forward looking statements or any change in events, conditions or circumstances on which any such statement is based. Nothing in these materials shall under any circumstances create an implication that there has been no changed in the affairs of the Group since the date of these materials.

==> picture [178 x 83] intentionally omitted <==

2

Morgans Technology Conference | November 24, 2021

WHERE HAS THE BUSINESS COME FROM? Inspired mind of our Founder and his ultimate vision to free the human inside, no matter how locked in, through wireless wearable technology connected to body. We are just beginning to understand what’s possible. “The totally wired user”

Peter Ford Founder

==> picture [178 x 83] intentionally omitted <==

3

Morgans Technology Conference | November 24, 2021

mission To be the global leader in innovative augmentative communications and control devices

==> picture [178 x 83] intentionally omitted <==

4

Morgans Technology Conference | November 24, 2021

• WoRLD CLASS AUSTRALIAN Wireless

• Wearable EMG TECHNOLOGY • Leading EMG Technology

• Spatial orientation technology

• Low latency brain intent activation via EMG

• 24hr battery

• Non Invasive

• Connects to speech generating software • Windows, iOS, Android

• Allows locked in or compromised people to control TVs, air-conditioners, doors, computer games & robots.

•

5

Morgans Technology Conference | November 24, 2021

Creating Market WINNING ProdUCTS We combined our NeuroNode wearable technology with high quality eye-gaze camera technology creating market leading products that delivered faster communication speed and significantly less fatigue than existing competition globally.

==> picture [800 x 400] intentionally omitted <==

==> picture [1037 x 548] intentionally omitted <==

==> picture [178 x 83] intentionally omitted <==

6

Morgans Technology Conference | November 24, 2021

Morgans Technology Conference | November 24, 2021

Our Products

• World class patented NeuroNode technology

• • Two primary assistive communication technology solutions for disability sector globally

==> picture [1007 x 698] intentionally omitted <==

==> picture [1013 x 677] intentionally omitted <==

==> picture [178 x 83] intentionally omitted <==

8

Morgans Technology Conference | November 24, 2021

==> picture [1774 x 885] intentionally omitted <==

----- Start of picture text -----

TECHNOLOGY ROADMAP
2022 2023 2024 2025 2030
----- End of picture text -----

==> picture [178 x 83] intentionally omitted <==

Morgans Technology Conference | November 24, 2021

9

• GloBAL GROWTH PLAN SINCE IPO Dec 2020

• • Strategic Priorities FY21 • Increased expansion in Australian assistive technology sector

• • Increased expansion in North America assistive technology sector

• • International expansion Japan & Singapore

• • Investment in R&D to enhance product range & miniaturise our

• core NN technology

==> picture [178 x 83] intentionally omitted <==

10

Morgans Technology Conference | November 24, 2021

• Exciting, SuCCESSFUL & Challenging FY21

• • Revenue of $3.97m

• • Investment year with 28% YOY growth in revenue despite COVID-19 business impact

• • Solid growth in key regions of USA and Australia

• • Strong balance sheet with $12.3m in cash as at June 30th

• • Top 10 Financial Review Boss Most Innovative Companies - Health Industries

11

Morgans Technology Conference | November 24, 2021

make a life–changing connection

==> picture [1149 x 646] intentionally omitted <==

==> picture [178 x 83] intentionally omitted <==

12

Morgans Technology Conference | November 24, 2021

• MOMENTUM FOR the year ahead

==> picture [178 x 83] intentionally omitted <==

13

Morgans Technology Conference | November 24, 2021

• Significant Addressable Market (Current Focus)

Type to enter a caption.

==> picture [178 x 83] intentionally omitted <==

14

Morgans Technology Conference | November 24, 2021

Momentum with Senior Global Management Team

==> picture [330 x 220] intentionally omitted <==

==> picture [231 x 308] intentionally omitted <==

----- Start of picture text -----

Todd Tyler
Vice President
North America
----- End of picture text -----

==> picture [517 x 375] intentionally omitted <==

----- Start of picture text -----

Rob Wong Neale Java
CEO CFO
Chris Feighner Stacey Berard
Global Production Funding Manager
& Quality Control USA
----- End of picture text -----

==> picture [303 x 202] intentionally omitted <==

==> picture [150 x 69] intentionally omitted <==

----- Start of picture text -----

Jamie Lemsing
International
Development
----- End of picture text -----

==> picture [311 x 208] intentionally omitted <==

==> picture [207 x 207] intentionally omitted <==

==> picture [304 x 202] intentionally omitted <==

==> picture [151 x 44] intentionally omitted <==

----- Start of picture text -----

James Schorey
CTO
----- End of picture text -----

==> picture [206 x 66] intentionally omitted <==

----- Start of picture text -----

Peter Ford
Director of Innovation
– new markets
----- End of picture text -----

Annette Curry Australia Region Sales Director

==> picture [203 x 202] intentionally omitted <==

==> picture [298 x 198] intentionally omitted <==

Alex Alvarado Product Development & Training Manager

==> picture [194 x 65] intentionally omitted <==

----- Start of picture text -----

Meagan Koeneman
North America
Sales Director
----- End of picture text -----

Kristen Learning & Education Manager

==> picture [178 x 83] intentionally omitted <==

15

Morgans Technology Conference | November 24, 2021

• Key Priorities 2021/22

• Revenue Growth

• • Revenue growth focus in Australia and North America through partners and sales team channels post COVID-19

• Operating Expenditure • Optimise productivity and strategic investments

• • Product leadership • NEW branding and marketing investment in awareness

• • NEW expanded product range within assistive technology market (autism)

• • Rental model rollout

• New International Markets • Opening up of Japan market post COVID-19

• • Expand presence in Singapore

• • International market entry post COVID (Europe & Asia)

• • R&D • Developing road map for NeuroNode wearable technology in selected markets

• • Developing wheelchair control project with Deakin University

==> picture [178 x 83] intentionally omitted <==

16

Morgans Technology Conference | November 24, 2021

• Expanded Product Range FY22

==> picture [178 x 83] intentionally omitted <==

`

17

Morgans Technology Conference | November 24, 2021

• New Product - Australia Launch

==> picture [232 x 122] intentionally omitted <==

• Compact handheld device speech generating software with detachable speaker, keyboard guides • Launched in Australia Q2, 2022

• Estimated there are 164,000 people in Australia with autism, 58% have communication disabilities, and 43,000 are registered with NDIS*.

• • The product is expected to complement the Control Bionics AAC range.

• https://www.aihw.gov.au/reports/disability/autism-in-australia/contents/autism

==> picture [178 x 83] intentionally omitted <==

18

Morgans Technology Conference | November 24, 2021

• NEW COSMOS CoNNECT PlUG-IN

to • Allows single switch users connect to multiple components like XBOX game consoles, feeding robots, iOS devices, Android devices and toys. • Includes Pilot Mode so users can play with friends and family

==> picture [534 x 366] intentionally omitted <==

• Expected to be a strong sales add-on for core Control Bionics AAC systems. Until now, many people in our target audience have been locked out of these life enjoying experiences.

• Launch Australia and USA Q2, 2022.

==> picture [178 x 83] intentionally omitted <==

`

19

Morgans Technology Conference | November 24, 2021

innovation ROADMAP

• Extension markets for NeuroNode IP & users. More control of environment and wheelchair transport. R&D partnership with Deakin University for wheelchair control.

• • Taps Global $5.4B (2027), CAGR 7.3%, power wheelchair market.*

==> picture [709 x 465] intentionally omitted <==

==> picture [250 x 166] intentionally omitted <==

• marketwatch.com/press-release/electric-wheelchair-market-sizeshare-2021

==> picture [178 x 83] intentionally omitted <==

20

Morgans Technology Conference | November 24, 2021

innovation ROADMAP

• More control & monitoring applications to disability markets and beyond through miniaturisation of our technology, on the road towards the “totally wired user”. More news in Q3.

==> picture [532 x 478] intentionally omitted <==

• Global Medical Patient Monitoring Market $23.3B, 2020, CAGR 6.9%. Wireless segment 7.3%*

• Global elderly disabled assistive devices market $23B, 2018, GAGR 5.5%**

• Global wearable technology market size $40B, 2020, CAGR 13.8%***

• www.gminsights.com/industry-analysis/patient-monitoring-devices-market

• **www.alliedmarketresearch.com/elderly-and-disabled-assistive-devices-market

• ** * www.grandviewresearch.com /industry-analysis/wearable-technology-markete

==> picture [178 x 83] intentionally omitted <==

20

Morgans Technology Conference | November 24, 2021

contact

==> picture [440 x 294] intentionally omitted <==

Rob Wong CEO robwong@controlbionics.com +61 419238768

==> picture [441 x 294] intentionally omitted <==

Brett Crowley Company Secretary brettcrowley@controlbionics.com +61 3 9897 3576

==> picture [178 x 83] intentionally omitted <==

21

Morgans Technology Conference | November 24, 2021